{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:57:00Z","timestamp":1765727820564},"reference-count":5,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T00:00:00Z","timestamp":1501286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>The earliest biomarkers introduced to diagnose myocardial infarction (MI) such as aspartate aminotransferase (AST) and lactic dehydrogenase (LDH) lacked cardiac specificity and were replaced by creatine kinase (CK), the CK\u2010MB isoenzyme, and ultimately the cardiac\u2010specific troponins (cTnT and cTnI). This has opened up the possibilities of ruling out MI more rapidly and also identifying patients with a chronic elevation of cTn and a poor prognosis in a range of cardiac conditions.<\/jats:p>","DOI":"10.1002\/cpt.773","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T07:52:46Z","timestamp":1501314766000},"page":"31-33","source":"Crossref","is-referenced-by-count":11,"title":["The Introduction and Clinical Use of Cardiac\u2010Specific Troponin Assays"],"prefix":"10.1111","volume":"103","author":[{"given":"Elliott M.","family":"Antman","sequence":"first","affiliation":[{"name":"Brigham and Women's Hospital TIMI Study Group Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,29]]},"reference":[{"key":"e_1_2_7_1_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcme.2015.04.003","article-title":"Biomarkers in acute coronary syndrome","volume":"8","author":"Martin D.","year":"2015","journal-title":"IJC Metab. Endocr."},{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(89)90680-9"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.255109"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.023697"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2562"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.773","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:35:37Z","timestamp":1699364137000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,29]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/cpt.773"],"URL":"https:\/\/doi.org\/10.1002\/cpt.773","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,29]]}}}